Email Us Here

[Pangyo Technovalley, Innovation hub in ASIA] Genome & Company Develops New Drug Development Pipeline and Platform

- Applied domestic patent for oral microbiome treatment candidate GEN-001 - Succeeded in attracting new investment in pre-IPO worth KRW 20 billion from KDB